Impaired Angiogenic Function of Fetal Endothelial Progenitor Cells via PCDH10 in Gestational Diabetes Mellitus

Int J Mol Sci. 2023 Nov 8;24(22):16082. doi: 10.3390/ijms242216082.

Abstract

Maternal hyperglycemia, induced by gestational diabetes mellitus (GDM), has detrimental effects on fetal vascular development, ultimately increasing the risk of cardiovascular diseases in offspring. The potential underlying mechanisms through which these complications occur are due to functional impairment and epigenetic changes in fetal endothelial progenitor cells (EPCs), which remain less defined. We confirm that intrauterine hyperglycemia leads to the impaired angiogenic function of fetal EPCs, as observed through functional assays of outgrowth endothelial cells (OECs) derived from fetal EPCs of GDM pregnancies (GDM-EPCs). Notably, PCDH10 expression is increased in OECs derived from GDM-EPCs, which is associated with the inhibition of angiogenic function in fetal EPCs. Additionally, increased PCDH10 expression is correlated with the hypomethylation of the PCDH10 promoter. Our findings demonstrate that in utero exposure to GDM can induce angiogenic dysfunction in fetal EPCs through altered gene expression and epigenetic changes, consequently increasing the susceptibility to cardiovascular diseases in the offspring of GDM mothers.

Keywords: PCDH10; angiogenesis; endothelial progenitor cells; epigenetic changes; gestational diabetes mellitus.

MeSH terms

  • Cardiovascular Diseases*
  • Diabetes, Gestational* / metabolism
  • Endothelial Progenitor Cells* / metabolism
  • Female
  • Fetus / metabolism
  • Humans
  • Hyperglycemia* / metabolism
  • Pregnancy
  • Protocadherins

Substances

  • PCDH10 protein, human
  • Protocadherins